XML 49 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Balance Sheets (USD $)
Dec. 31, 2012
Dec. 31, 2011
Current assets:    
Cash and cash equivalents $ 868,067 $ 561,759
Short-term investment 39,249 39,110
Accounts receivable, net 284,395 143,320
Costs and estimated earnings in excess of billings on uncompleted contracts 36,476 66,454
Inventory 48,011   
Prepaid expenses and other current assets 1,405   
Total current assets 1,277,603 810,643
Equipment, net 6,064 8,058
Debt issuance costs, net 103,632   
Totals 1,387,299 818,701
Current liabilities:    
Accounts payable and accrued expenses 343,080 558,277
Accrued compensation and related costs    73,888
Accrued interest, related party 20,439 12,219
Related party accounts payable and accrued expenses 102,856 86,885
Related party notes payable 73,500 73,500
Billings in excess of costs and estimated earnings on uncompleted contracts 69,789   
Deferred revenue 201,117   
Conversion option liabilities 69,502   
Warrant liabilities 345,221 198,471
Total current liabilities 1,225,504 1,003,240
Convertible debentures, net 685,692   
Total liabilities 1,911,196 1,003,240
Commitments      
Stockholders' equity (deficiency):    
Preferred stock, $0.01 par value, 5,000,000 shares authorized; 0 issued and outstanding at December 31, 2012 and 2011      
Common stock, $0.01 par value, 100,000,000 shares authorized; 42,198,093 issued and outstanding at December 31, 2012, 39,779,506 issued and outstanding at December 31, 2011 421,981 397,795
Additional paid-in capital 6,091,469 4,688,417
Accumulated deficiency (7,036,776) (5,270,751)
Accumulated other comprehensive loss (571)   
Total stockholders' deficiency (523,897) (184,539)
Totals $ 1,387,299 $ 818,701